Peregrine Pharmaceuticals shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $421k | 34k | 12.35 |
| 2024-09-30 | $276k | 24k | 11.38 |
| 2024-06-30 | $178k | 25k | 7.14 |
| 2024-03-31 | $156k | 23k | 6.70 |
| 2023-12-31 | $134k | 21k | 6.50 |
| 2023-09-30 | $494k | 52k | 9.44 |
| 2023-06-30 | $963k | 69k | 13.97 |
| 2022-12-31 | $103k | 7.5k | 13.77 |
| 2022-09-30 | $207k | 11k | 19.09 |
| 2022-06-30 | $170k | 11k | 15.26 |
| 2022-03-31 | $1.9M | 94k | 20.37 |
| 2021-12-31 | $3.2M | 110k | 29.33 |
| 2021-09-30 | $7.4M | 358k | 20.62 |
| 2021-06-30 | $4.7M | 181k | 25.77 |
| 2021-03-31 | $3.1M | 171k | 18.23 |
| 2020-12-31 | $1.6M | 141k | 11.55 |
| 2020-09-30 | $1.1M | 140k | 7.61 |
| 2020-06-30 | $937k | 143k | 6.56 |
| 2020-03-31 | $477k | 93k | 5.11 |
| 2019-12-31 | $1.4M | 176k | 7.67 |
| 2019-09-30 | $931k | 176k | 5.30 |
| 2019-06-30 | $909k | 162k | 5.60 |
| 2019-03-31 | $576k | 136k | 4.25 |
| 2018-12-31 | $399k | 97k | 4.11 |
| 2018-09-30 | $544k | 79k | 6.85 |
| 2018-06-30 | $1.0M | 262k | 3.91 |
| 2018-03-31 | $643k | 220k | 2.92 |